Supernus Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/18/2026 | 746 | 0.0% | 15,490 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 1,033 | 0.0% | 21,622 | 9/30/2025 |
| 2025 Q2 | 8/15/2025 | 419 | 0.0% | 13,289 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 435 | 0.0% | 13,289 | 3/31/2025 |
| 2024 Q4 | 2/13/2025 | 481 | 0.0% | 13,289 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 572 | 0.0% | 18,351 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 394 | 0.0% | 14,722 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 502 | 0.0% | 14,722 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 724 | 0.0% | 25,027 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 737 | 0.0% | 26,734 | 9/30/2023 |
| 2023 Q2 | 8/15/2023 | 915 | 0.0% | 30,449 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 1,148 | 0.0% | 31,675 | 3/31/2023 |
| 2022 Q4 | 2/15/2023 | 1,121 | 0.0% | 31,435 | 12/31/2022 |
| 2022 Q3 | 1/26/2023 | 1,064 | 0.0% | 31,435 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 812 | 0.0% | 28,064 | 6/30/2022 |
| 2022 Q1 | 5/11/2022 | 1,007 | 0.0% | 31,174 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 820 | 0.0% | 28,129 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 751 | 0.0% | 28,129 | 9/30/2021 |
| 2021 Q2 | 8/11/2021 | 922 | 0.0% | 29,945 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 909 | 0.0% | 34,712 | 3/31/2021 |
| 2020 Q4 | 2/9/2021 | 1,066 | 0.0% | 42,387 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 848 | 0.0% | 40,704 | 9/30/2020 |
| 2020 Q2 | 8/13/2020 | 933 | 0.0% | 39,269 | 6/30/2020 |
| 2020 Q1 | 5/28/2020 | 633 | 0.0% | 35,216 | 3/31/2020 |
| 2019 Q4 | 2/6/2020 | 941 | 0.0% | 39,685 | 12/31/2019 |